Developing Research Capacity in Africa for Studies on HIV-Associated Malignancies (D43)

The summary for the Developing Research Capacity in Africa for Studies on HIV-Associated Malignancies (D43) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Developing Research Capacity in Africa for Studies on HIV-Associated Malignancies (D43): Purpose. The purpose of this Funding Opportunity announcement (FOA) is to strengthen research capacity in HIV-associated malignancies in sub-Saharan Africa. This FOA solicits applications for strategic, collaborative cancer research training programs based on partnerships between United States (U.S.) and African researchers. These training programs are expected to build multidisciplinary research teams of African investigators, including physicians, other clinical scientists, basic research scientists, epidemiologists, pathologists, data managers and other required personnel. It is anticipated that the creation of these teams will strategically enhance the capacity for innovative research in HIV-associated malignancies at institutions in Africa. As a long-term goal (beyond the scope of this FOA), the NCI envisions that the training programs will allow African teams of scientists to become fully efficient and productive as partners with investigators from developed countries in future research endeavors oriented on HIV-associated malignancies in sub-Saharan Africa. In line with this goal, research training programs proposed in response to this FOA must be strongly oriented on facilitating future hypothesis driven studies in HIV-associated malignancies that could compete for support from other funding sources. Mechanism of Support. This FOA will utilize the NIH D43 grant mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that $4.0 million per year will be available for this initiative for 6-7 awards. Facilities and administrative costs are limited to 8% for all awards and sub-awards.